Carbetocin

Раствор By prescription

Oxytocin receptor selective agonist

Carbetocin

Indications

Prevention of uterine atony after extraction of the baby during surgical delivery by cesarean section with epidural or spinal anesthesia

Contraindications

  • Hypersensitivity to carbetocin, oxytocin or to any of the components of the drug
  • The period of pregnancy and the prenatal period
  • Application for the purpose of labor induction
  • Impaired liver or kidney function
  • Severe diseases of the cardiovascular system that occur against the background of vasospastic conditions (including uncontrolled hypertension), cardiac arrhythmias and conduction
  • Preeclampsia and eclampsia, epilepsy

 

With caution

Carbetocin® should be used with caution in migraines, bronchial asthma and cardiovascular diseases, as well as in any conditions in which a rapid increase in extracellular fluid volume can provoke complications associated with hyperhydration. The decision on the appointment of Carbetocin® should be made by the doctor taking into account the benefit–risk ratio in each specific case.

Use during pregnancy and lactation

Carbetocin is contraindicated during pregnancy and childbirth until the time of extraction of the child.

A small amount of carbetocin can enter breast milk of  mother and then be destroyed in the gastrointestinal tract of the newborn by proteolytic enzymes.

Usage

Carbetocin® is administered once intravenously or intramuscularly only after the birth of a child.

  • The drug should not be reused
  • Carbetocin should not be mixed with other drugs in the same syringe
  • Do not use the drug if insoluble particles are observed in the solution or the solution has changed color
  • Unused drug must be destroyed

During cesarean section, one dose of carbetocin (100 mcg) is administered once immediately after the baby is extracted, preferably before the placenta is separated.

During delivery through the natural birth canal, one dose of carbetocin (100 mcg) is injected into the upper thigh, immediately after the placenta is isolated.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.